While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the ...

With oligonucleotides on the rise to treat rare diseases and cancers, Japanese manufacturer Nitto Denko is laying big plans. Nitto will plug a whopping 25 billion yen ($225.93 million) into its ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

If you have been watching Nitto Denko's stock, you know the ride has been exciting lately. With a year-to-date climb of 31.0% and an impressive 50.2% return over just the past twelve months, it is ...

OSAKA, Japan--(BUSINESS WIRE)--In response to the rapid market expansion of oligonucleotide therapeutics that have potential to treat both common and intractable diseases, Nitto Denko Corporation ...

Showa Denko K.K., Japan’s No. 3 diversified chemicals supplier, agreed to pay more than double its own market value to buy its bigger rival Hitachi Chemical Co., to scale up its lithium-ion battery ...

Inaba Denko, a manufacturer of HVAC and refrigeration installation accessories formed in Japan over 85 years ago, has recently expanded its global reach by establishing Inaba Denko America Inc., based ...

TOKYO, Mar 18, 2020 - (JCN Newswire) - - Showa Denko Packaging Co., Ltd. (SPA), a consolidated subsidiary of Showa Denko K.K. (SDK; TSE:4004), has developed a new product to be added to the lineup of ...

Find the Nitto Denko Co financial statements for a comprehensive overview of the company’s financial health. This summary highlights critical numbers from key financial reports, including the Nitto ...

Showa Denko K.K., a key chemicals supplier to global chipmakers like Taiwan Semiconductor Manufacturing Co., is overhauling its executive team and company culture in anticipation of an industry shift ...

Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis’s ECO Synthesis® Manufacturing Platform for Therapeutic siRNA Manufacturing Redwood City, CA — [October 30, 2025] — Codexis ...

Determining whether Nitto Denko Co—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Nitto ...